Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-16-053380

Options or other derivatives

  • Senior VP - Drug Discovery acquired 129,427 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-05-23 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +129,427 $3.22 2026-05-23 129,427 129,427 D
Loading xslF345X03/form4.xml…